Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Effectiveness of a Novel Remineralizing Agent: A Randomized Controlled Clinical Trial

NCT06131294 is registered in ClinicalTrials.gov with Ivoclar Vivadent AG as lead sponsor.

NCT NCT06131294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06131294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Effectiveness of a Novel Remineralizing Agent: A Randomized Controlled Clinical Trial
Lead sponsor
Ivoclar Vivadent AG
Phase
Not applicable
Overall status
Completed
Start date
February 24, 2023
Completion date
April 16, 2024
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

white spot lesion